Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Allosteric Regulation of SULT1A1 by Mefenamic Acid
NCT03383133Phase 1Completed
- Sponsor
- Albert Einstein College of Medicine
- Start
- Jan 2018
- Primary completion
- Feb 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of Mefenamic acid in Drug toxicity, sponsored by Albert Einstein College of Medicine. Primary endpoint: Acetaminophen and Dehydroepiandrosterone Conjugates at 12 hours. Started Jan 2018; status: completed.
02
Drugs
Mefenamic acid
03
Conditions
Drug toxicity
Beyond the preview
Go deeper on NCT03383133.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03383133.